Proton Pump Inhibitors: Difference between revisions
From Glioblastoma Treatments
Jump to navigationJump to search
(Created page with "{{TreatmentInfo |drug_name=Proton Pump Inhibitors (e.g., Lansoprazole, Nexium) |FDA_approval=Yes (for heartburn and acid-related issues) |used_for=Investigational use in enhancing sensitivity of cancer cells to chemotherapy |clinical_trial_phase=Preclinical studies and observational studies in animals and humans |common_side_effects=Common PPI side effects include headache, nausea, diarrhea, abdominal pain, fatigue, and dizziness |OS_without=Not specified |OS_with=Studie...") |
No edit summary |
||
| Line 13: | Line 13: | ||
|category=Repurposed Drugs | |category=Repurposed Drugs | ||
|links= | |links= | ||
|toxicity_level=2 | |||
|toxicity_explanation=The drug being tested, a Proton Pump Inhibitor, is commonly used for heartburn and acid-related issues, and is now being tested for its potential benefits in treating cancer. Its side effects include common, non-severe symptoms like headache, nausea, diarrhea, abdominal pain, fatigue, and dizziness. Although these can be uncomfortable, they are manageable and often temporary. Thus, we rate its toxicity a 2 out of 5. However, the drug is still under preclinical and observational studies for its use in cancer treatment, meaning its effects are not fully understood. Always consult with your physician when considering new treatments. | |||
}} | }} | ||
Revision as of 08:52, 27 March 2024
| Property | Information |
|---|---|
| Drug Name | Proton Pump Inhibitors (e.g., Lansoprazole, Nexium) |
| FDA Approval | Yes (for heartburn and acid-related issues) |
| Used for | Investigational use in enhancing sensitivity of cancer cells to chemotherapy |
| Clinical Trial Phase | Preclinical studies and observational studies in animals and humans |
| Clinical Trial Explanation | Not specified |
| Common Side Effects | Common PPI side effects include headache, nausea, diarrhea, abdominal pain, fatigue, and dizziness |
| OS without | Not specified |
| OS with | Studies suggest PPIs may improve progression-free survival in cancer treatment |
| PFS without | 7.5 months in metastatic breast cancer patients receiving only chemotherapy |
| PFS with | 9.5 months with 100 mg Nexium; 10.9 months with 80 mg Nexium |
| Usefulness Rating | 3 |
| Usefulness Explanation | Not specified |
| Toxicity Level | 2 |
| Toxicity Explanation | The drug being tested, a Proton Pump Inhibitor, is commonly used for heartburn and acid-related issues, and is now being tested for its potential benefits in treating cancer. Its side effects include common, non-severe symptoms like headache, nausea, diarrhea, abdominal pain, fatigue, and dizziness. Although these can be uncomfortable, they are manageable and often temporary. Thus, we rate its toxicity a 2 out of 5. However, the drug is still under preclinical and observational studies for its use in cancer treatment, meaning its effects are not fully understood. Always consult with your physician when considering new treatments. |
Notes: PPIs, commonly used for acid-related stomach issues, may suppress tumor growth by disrupting cancer cells' acid extrusion. Pre-treatment with PPIs has shown to sensitize cancer cells to cytotoxic drugs and improve treatment outcomes in preliminary studies. Further research is necessary to understand the optimal dosing and clinical efficacy in human cancer treatment.
From Ben Williams Book: Not specified
Loading comments...
